Dr. Mehmet Oz and Dr. Marty Makary touted that reducing steps for biosimilar approval will lower costs by increasing competition.
Once those prices are set, most large government programs that cover prescription drugs pay prices that are tied to ...
Laws focused lowering drug prices have expanded in 15 states, with new boards and payment limits shaping affordability since 2017.
Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...
New analysis finds the median net price for 154 newly launched drugs, when adjusted for inflation and manufacturer discounts, ...
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...
By Patrick Wingrove and Puyaan Singh (Reuters) -AbbVie said on Friday the Trump administration was pushing for steeper cuts ...
The price of Rebif has increased four times faster than the rate of inflation, with Kay's insurer deciding to stop covering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback